Large-scale testing (Phase 3)Study completedNCT02469857
What this trial is testing
Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections
Who this might be right for
Necrotizing Soft Tissue InfectionsNecrotizing FasciitisFournier's Gangrene
Atox Bio Ltd 290